NCT03743519

Brief Summary

Patellofemoral pain (PFP) is the most common chronic pathology in sports medicine and physiotherapy clinics. As pain and inflammation are the main symptoms of PFP, non-steroidal anti-inflammatory and analgesic medications are often utilized to decrease pain and inflammation; however alternative treatments are increasingly being sought due to the cardiovascular and gastrointestinal side effects of traditional pain medications. Most researchers advocate conservative treatment, though there is still insufficient clarity regarding the effectiveness of conservative treatment modalities. Dietary interventions for PFP have not received any attention in clinical literature, yet there is a growing body of evidence indicating that cherries have significant anti-inflammatory, antioxidant and pain-mediating effects. Therefore, the primary purpose of the proposed investigation was to test (using a randomized control investigation) the ability of a tart cherry juice blend to provide symptom relief in recreational athletes with PFP and to understand the biological and mechanical mechanisms behind any changes in PFP symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 16, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

May 30, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

July 21, 2020

Status Verified

May 1, 2019

Enrollment Period

1 year

First QC Date

November 10, 2018

Last Update Submit

July 20, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee injury and Osteoarthritis Outcome Score (KOOS) - patellofemoral scale

    This is a questionnaire based measurement that allows participants to subjectively rate the extent of their patellofemoral pain symptoms. This measurement is scored on a 0-100 scale with 100 indicating no pain.

    6-weeks

Secondary Outcomes (6)

  • COOP-WONCA - psychological wellbeing

    6-weeks

  • Plasma urate

    6-weeks

  • Creatinine

    6-weeks

  • human TNF-alpha

    6-weeks

  • High sensitivity C-reactive protein

    6-weeks

  • +1 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Placebo

Cherry juice

EXPERIMENTAL
Dietary Supplement: Cherry juice

Interventions

Cherry juiceDIETARY_SUPPLEMENT

30 mL of tart cherry juice concentrate, which will be diluted with 200 mL of water.

Cherry juice
PlaceboDIETARY_SUPPLEMENT

Identical in taste and colour to the Cherry juice, but with no anthocyanin content

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recreationally active
  • Suffering from mild to moderate patellofemoral pain with no evidence of any other condition.

You may not qualify if:

  • Rheumatoid arthritis or other systemic inflammatory condition
  • Chronic pain syndrome
  • Corticosteroid medication in last 2 months (intra-articular or oral)
  • Intra-articular injections of hyaluronic acid in the last 9 months
  • Pregnancy
  • Diabetes
  • Food allergies to cherries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Central Lancashire

Preston, Lancs, PR1 2HE, United Kingdom

Location

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

November 10, 2018

First Posted

November 16, 2018

Study Start

May 30, 2019

Primary Completion

May 30, 2020

Study Completion

June 1, 2020

Last Updated

July 21, 2020

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations